At 60 days there's no difference, and at 140 days there's no difference (as per the chart above). At 90 days there's a 2% difference in a non-statistically significant population.
There's absolutely no evidence yet that it's clinically effective.
It is that simple, and the other points raised in that study have been convenientaly ignored. Leaving this thread to the time wasters.
News: CSL UPDATE 1-CSL's half-year profit beats estimates on robust blood plasma collections, page-40
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$295.21 |
Change
0.050(0.02%) |
Mkt cap ! $143.3B | |||
| Open | High | Low | Value | Volume |
| $296.30 | $298.20 | $295.00 | $229.6M | 780.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 248 | $295.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $295.21 | 42 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| CSL (ASX) Chart |